PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2019.007202052185-97SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung CancerYoo-Kang Kwak, Hee Hyun Park, Kyu Hye Choi, Eun Young Park, Soo Yoon Sung, Sea-Won Lee, Ji Hyun Hong, Hyo Chun Lee, Ie Ryung Yoo, Yeon Sil Kimhttp://e-crt.org/upload/pdf/crt-2019-007.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2019.007, http://e-crt.org/upload/pdf/crt-2019-007.pdf
Clinical Lung Cancer10.1016/j.cllc.2013.12.0112014154294-301.e3Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiotherapy for Stage I Non–Small-Cell Lung CancerDavid B. Shultz, Nicholas Trakul, Jonathan A. Abelson, James D. Murphy, Peter G. Maxim, Quynh-Thu Le, Billy W. Loo, Maximilian Diehnhttps://api.elsevier.com/content/article/PII:S1525730414000230?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730414000230?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(09)70227-2200964S45-S46104PD CHARLSON CO-MORBIDITY INDEX PREDICTS FOR MORTALITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR MEDICALLY INOPERABLE EARLY STAGE NON-SMALL CELL LUNG CANCERN. Kopek, C. Grau, M. Hoyerhttps://api.elsevier.com/content/article/PII:S0169500209702272?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500209702272?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(15)50130-x201587S49-S50136: Review of CT imaging following stereotactic ablative radiotherapy for stage 1 non small cell lung cancerA.C. Pascoe, K. Foweraker, C. Esler, S. Morganhttps://api.elsevier.com/content/article/PII:S016950021550130X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S016950021550130X?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(16)30155-6201691S50138 Stage I non small cell lung cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative radiotherapyK. Thippu Jayaprakash, D. Gilligan, S. Hardenhttps://api.elsevier.com/content/article/PII:S0169500216301556?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500216301556?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(13)70171-5201379S58171 Stereotactic ablative radiotherapy (SABR) in medically inoperable early stage non-small cell lung cancer (NSCLC): A single tertiary UK centre experienceC. Yip, D.B. Landau, C. Thomas, S. Ahmadhttps://api.elsevier.com/content/article/PII:S0169500213701715?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500213701715?httpAccept=text/plain
Radiotherapy and Oncology10.1016/s0167-8140(11)71656-5201199S570-S5711534 poster STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCERG. Beltramo, A. Bergantin, A. Martinotti, P. Bonfanti, L.C. bianchihttps://api.elsevier.com/content/article/PII:S0167814011716565?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167814011716565?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(19)30222-32019127S74Acute radiation induced CT changes after stereotactic ablative body radiotherapy for primary non-small cell lung cancerH. Saxby, E. Chandy, I. Phillips, V. Prakash, V. Ezhilhttps://api.elsevier.com/content/article/PII:S0169500219302223?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500219302223?httpAccept=text/plain
The Lancet Oncology10.1016/s1470-2045(12)70242-52012138802-809Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysisSashendra Senthi, Frank J Lagerwaard, Cornelis JA Haasbeek, Ben J Slotman, Suresh Senanhttps://api.elsevier.com/content/article/PII:S1470204512702425?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1470204512702425?httpAccept=text/plain
The Oncologist10.1634/theoncologist.2015-04772016214393-398Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force AwakensShankar Siva, David Ballhttps://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2015-0477, https://onlinelibrary.wiley.com/doi/full-xml/10.1634/theoncologist.2015-0477, https://academic.oup.com/oncolo/article-pdf/21/4/393/41874753/oncolo_21_4_393.pdf, https://academic.oup.com/oncolo/article-pdf/21/4/393/41874753/oncolo_21_4_393.pdf